Insider Transactions in Q2 2022 at La Jolla Pharmaceutical CO (LJPC)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jun 30 2022	Michael S Hearne Chief Financial Officer	BUY Grant, award, or other acquisition	Direct	236 +2.26%	$472 $2.71 P/Share
Jun 15 2022	Michael S Hearne Chief Financial Officer	BUY Grant, award, or other acquisition	Direct	236 +2.32%	$472 $2.72 P/Share
May 31 2022	Michael S Hearne Chief Financial Officer	BUY Grant, award, or other acquisition	Direct	189 +1.91%	$567 $3.41 P/Share
May 13 2022	Michael S Hearne Chief Financial Officer	BUY Grant, award, or other acquisition	Direct	188 +1.94%	$564 $3.41 P/Share
Apr 29 2022	Michael S Hearne Chief Financial Officer	BUY Grant, award, or other acquisition	Direct	185 +1.94%	$555 $3.47 P/Share
Apr 14 2022	Michael S Hearne Chief Financial Officer	BUY Grant, award, or other acquisition	Direct	173 +1.86%	$519 $3.71 P/Share
Apr 14 2022	Larry G. Edwards Chief Executive Officer	BUY Grant, award, or other acquisition	Direct	296 +2.41%	$888 $3.71 P/Share

Receive a notification when an Institution or Guru buys or sells LJPC shares.

Notify only if

Value

Get notified when an La Jolla Pharmaceutical CO insider buys or sells LJPC shares.

Notify only if

Operation

Value

Type

Receive news related to LA JOLLA PHARMACEUTICAL CO